129 related articles for article (PubMed ID: 22105006)
21. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
22. Treatment with monoclonal antibodies against Clostridium difficile toxins.
Lowy I; Molrine DC; Leav BA; Blair BM; Baxter R; Gerding DN; Nichol G; Thomas WD; Leney M; Sloan S; Hay CA; Ambrosino DM
N Engl J Med; 2010 Jan; 362(3):197-205. PubMed ID: 20089970
[TBL] [Abstract][Full Text] [Related]
23. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
24. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Buggy BP; Fekety R; Silva J
J Clin Gastroenterol; 1987 Apr; 9(2):155-9. PubMed ID: 3571889
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea.
Beales IL
Gut; 2002 Sep; 51(3):456. PubMed ID: 12171976
[No Abstract] [Full Text] [Related]
26. Clostridium difficile infection causing multiple organ failure and small-bowel enteritis.
Hariri S; Gouin P; Tuech JJ; Veber B; Dureuil B
Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):142-4. PubMed ID: 21809490
[No Abstract] [Full Text] [Related]
27. Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Hung YP; Lin HJ; Wu CJ; Chen PL; Lee JC; Liu HC; Wu YH; Yeh FH; Tsai PJ; Ko WC
Anaerobe; 2014 Dec; 30():24-6. PubMed ID: 25102472
[TBL] [Abstract][Full Text] [Related]
28. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
Bakken JS
Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
[TBL] [Abstract][Full Text] [Related]
29. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.
Dudley MN; McLaughlin JC; Carrington G; Frick J; Nightingale CH; Quintiliani R
Arch Intern Med; 1986 Jun; 146(6):1101-4. PubMed ID: 3521518
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile.
Baird DR
J Antimicrob Chemother; 1989 Jan; 23(1):167-9. PubMed ID: 2745253
[No Abstract] [Full Text] [Related]
31. Clostridium difficile disease and vancomycin--questionable clinical superiority.
Tarchini G
Clin Infect Dis; 2011 Jul; 53(2):212. PubMed ID: 21690637
[No Abstract] [Full Text] [Related]
32. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile.
McFee RB; Abdelsayed GG
Dis Mon; 2009 Jul; 55(7):439-70. PubMed ID: 19540996
[No Abstract] [Full Text] [Related]
34. Emphysematous cystitis due to recurrent Clostridium difficile infection.
van Genderen ME; Jonkman JG; van Rijn M; Dees A
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519862
[TBL] [Abstract][Full Text] [Related]
35. Effect of treatment variation on outcomes in patients with Clostridium difficile.
Brown AT; Seifert CF
Am J Med; 2014 Sep; 127(9):865-70. PubMed ID: 24862310
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin "telephone".
Drekonja DM
Clin Infect Dis; 2011 Jul; 53(2):211-2. PubMed ID: 21690636
[No Abstract] [Full Text] [Related]
37. Clostridium difficile: new therapeutic options.
Balagopal A; Sears CL
Curr Opin Pharmacol; 2007 Oct; 7(5):455-8. PubMed ID: 17644040
[TBL] [Abstract][Full Text] [Related]
38. Probiotics for Clostridium difficile diarrhea: putting it into perspective.
Karpa KD
Ann Pharmacother; 2007 Jul; 41(7):1284-7. PubMed ID: 17595302
[TBL] [Abstract][Full Text] [Related]
39. Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2017 Jul; 53(7):385-392. PubMed ID: 28837182
[TBL] [Abstract][Full Text] [Related]
40. Rifaximin: new therapeutic indication and future directions.
Rivkin A; Gim S
Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
